Trial Profile
Phase 4 Study of Panic Disorder That Expresses to Change of Cerebral Glucose Metabolism After 12 Week of Paroxetine Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Panic disorder
- Focus Pharmacodynamics
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2008 New trial record.